Learner Objectives

After participating in this activity, learners should be able to:

Episode Specific:
  • Identify how health equity impacts patients’ access to treatment for OUD.
  • Describe ways to improve access to OUD treatment for marginalized patients.
  • Identify barriers to treatment access that relate to race, ethnicity, and LGBTQI communities.
  • Recall the goals of National Institute on drug abuse (NIDA) racial equity initiative.
Podcast Series:
  • Increase safe opioid prescribing practices in line with HB1427.
  • Have strategies to tailor opioid management services to their specialty and organization using evidence-based practices on appropriate prescribing and data-driven practices.
  • Help reduce the development of tolerance to opioids.
  • Address long-term pain management, and appropriately treat opioid addiction.
1=Poor23=Good45=Excellent
1=Poor23=Good45=Excellent
Content Expertise
Communication Skills
1=Poor23=Good45=Excellent
Content Expertise
Communication Skills

An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.

Did you perceive any bias toward a “commercial interest” in any presentation?
Do you want CME credit?(Required)